H. K. Park, M. Qatanani, E. R. Briggs, R. S. Ahima, and M. A. Lazar, Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice, Diabetes, vol.60, pp.775-783, 2011.

D. R. Schwartz and M. A. Lazar, Human Resistin: Found in Translation From Mouse to Man, Trends in endocrinology and metabolism: TEM, vol.22, pp.259-265, 2011.

C. Menzaghi, Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in highrisk individuals, Sci Rep, vol.7, 2017.

M. Filkova, M. Haluzik, S. Gay, and L. Senolt, The role of resistin as a regulator of inflammation: Implications for various human pathologies, Clin Immunol, vol.133, pp.157-170, 2009.

M. S. Jamaluddin, S. M. Weakley, Q. Yao, and C. Chen, Resistin: functional roles and therapeutic considerations for cardiovascular disease, Br J Pharmacol, vol.165, pp.622-632, 2012.

D. A. Vassiliadi, Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels, J Crit Care, vol.27, pp.400-409, 2012.

H. Asano, Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population, Diabetologia, vol.53, pp.234-246, 2010.

H. Onuma, A at single nucleotide polymorphism-358 is required for G at ?420 to confer the highest plasma resistin in the general Japanese population, PLoS One, vol.5, 2010.

B. H. Chen, Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men, International Journal of Molecular Epidemiology and Genetics, vol.1, pp.167-174, 2010.

Y. M. Cho, Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans, Diabetologia, vol.47, pp.559-565, 2004.

H. Osawa, Is rs34861192 or rs1862513 a more promising variant for determining plasma resistin in an aged Japanese population?, Diabetologia, vol.53, pp.795-797, 2010.

M. Nakatochi, Epigenome-wide association study suggests that SNPs in the promoter region of RETN influence plasma resistin level via effects on DNA methylation at neighbouring sites, Diabetologia, vol.58, pp.2781-2790, 2015.

H. Onuma, Dual Effects of a RETN Single Nucleotide Polymorphism (SNP) at ?420 on Plasma Resistin: Genotype and DNA Methylation, J Clin Endocrinol Metab, vol.102, pp.884-892, 2017.

L. Zhou, Transcriptional regulation of the resistin gene, Domest Anim Endocrinol, vol.30, pp.98-107, 2006.

S. S. Chung, Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site, Diabetologia, vol.48, pp.1150-1158, 2005.

A. K. Singh, A. Battu, K. Mohareer, S. E. Hasnain, and N. Z. Ehtesham, Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma), PLoS One, vol.5, 2010.

D. Kumar, A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus

, Genome Med, vol.9, 2017.

K. J. Puan, Systematic characterization of basophil anergy, Allergy, vol.72, pp.373-384, 2017.

A. K. Andiappan, Functional variants of 17q12-21 are associated with allergic asthma but not allergic rhinitis, J Allergy Clin Immunol, vol.137, pp.758-766, 2016.

A. K. Andiappan, Allergic airway diseases in a tropical urban environment are driven by dominant mono-specific sensitization against house dust mites, Allergy, vol.69, pp.501-509, 2014.

T. Raj, Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes, Science, vol.344, pp.519-523, 2014.

H. Osawa, The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3, Am J Hum Genet, vol.75, pp.678-686, 2004.

M. S. Hayden and S. Ghosh, NF-kappaB, the first quarter-century: remarkable progress and outstanding questions, Genes Dev, vol.26, pp.203-234, 2012.

S. R. Lewin, P. Lambert, N. J. Deacon, J. Mills, and S. M. Crowe, Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages, J Virol, vol.71, pp.2114-2119, 1997.

M. Frankenberger, Constitutive nuclear NF-kappa B in cells of the monocyte lineage, Biochem J, vol.304, pp.87-94, 1994.

T. Cartwright and N. D. Perkins, NFKB1: a suppressor of inflammation, ageing and cancer, FEBS J, vol.283, pp.1812-1822, 2016.

A. M. Elsharkawy, The NF-?B p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple proinflammatory genes, Journal of Hepatology, vol.53, pp.519-527, 2010.

, The Genomes Project, C. A global reference for human genetic variation, Nature, vol.526, 2015.

M. Calao, A. Burny, V. Quivy, A. Dekoninck, and C. Van-lint, A pervasive role of histone acetyltransferases and deacetylases in an NF-&#x3ba

B. Code, Trends in Biochemical Sciences, vol.33, pp.339-349

A. M. Deaton and A. Bird, CpG islands and the regulation of transcription, Genes & Development, vol.25, pp.1010-1022, 2011.

R. C. Del-rosario, Sensitive detection of chromatin-altering polymorphisms reveals autoimmune disease mechanisms, Nat Methods, vol.12, pp.458-464, 2015.

S. P. Macdonald, Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department, PLoS One, vol.9, 2014.

C. Menzaghi, Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes, PLoS One, vol.8, 2014.

Z. Gokmen, Resistin-a novel feature in the diagnosis of sepsis in premature neonates, Am J Perinatol, vol.30, pp.513-517, 2013.

S. M. Fadda, S. M. Gamal, N. Y. Elsaid, and A. M. Mohy, Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression, Z Rheumatol, vol.72, pp.594-600, 2013.

M. Akbar, Targeting danger molecules in tendinopathy: the HMGB1/TLR4 axis, RMD Open, vol.3, 2017.

A. Bangert, Critical role of RAGE and HMGB1 in inflammatory heart disease, Proc Natl Acad Sci, vol.113, pp.155-164, 2016.

J. A. Nogueira-machado, C. M. Volpe, C. A. Veloso, M. M. Chaves, and . Hmgb1, TLR and RAGE: a functional tripod that leads to diabetic inflammation, Expert Opin Ther Targets, vol.15, pp.1023-1035, 2011.

C. Shen, The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis, BMC Gastroenterol, vol.14, 2014.

Z. X. Dong, Resistin mediates the hepatic stellate cell phenotype, World J Gastroenterol, vol.19, p.4475, 2013.

R. S. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nature reviews. Immunology, vol.13, pp.862-874, 2013.

H. Poehlmann, J. C. Schefold, H. Zuckermann-becker, H. Volk, and C. Meisel, Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis, Critical Care, vol.13, 2009.

R. K. Strother, Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T-Cell Responses in vivo(), Journal of immunology, vol.197, pp.4301-4311, 1950.

I. Van-brussel, Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function, Clin Sci (Lond), vol.120, pp.415-426, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00660886

J. Wen, A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?, Heart Vessels, vol.28, pp.135-142, 2013.

A. Yilmaz, Decrease in circulating myeloid dendritic cell precursors in coronary artery disease, J Am Coll Cardiol, vol.48, pp.70-80, 2006.

C. K. Ea, S. Hao, K. S. Yeo, and D. Baltimore, EHMT1 protein binds to nuclear factor-kappaB p50 and represses gene expression, J Biol Chem, vol.287, pp.31207-31217, 2012.

D. Schubeler, Function and information content of DNA methylation, Nature, vol.517, pp.321-326, 2015.

C. E. Schlosberg, N. D. Vanderkraats, and J. R. Edwards, Modeling complex patterns of differential DNA methylation that associate with gene expression changes, Nucleic Acids Res, vol.45, pp.5100-5111, 2017.

C. Menzaghi, Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians, The Journal of clinical endocrinology and metabolism, vol.91, pp.2792-2795, 2006.

M. F. Hivert, Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study, Diabetes, vol.58, pp.750-756, 2009.

K. Azuma, Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Hormone and metabolic research = Hormon-und Stoffwechselforschung = Hormones et metabolisme, vol.36, pp.564-570, 2004.

S. R. Smith, F. Bai, C. Charbonneau, L. Janderova, and G. Argyropoulos, A promoter genotype and oxidative stress potentially link resistin to human insulin resistance, Diabetes, vol.52, pp.1611-1618, 2003.

M. D. Long, D. J. Smiraglia, and M. J. Campbell, The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer, Biomolecules, vol.7, 2017.

G. Beauchef, The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3), J Biol Chem, vol.287, pp.3462-3478, 2012.

X. Ye, H. Liu, Y. S. Gong, S. F. Liu, and . Lps, Down-Regulates Specificity Protein 1 Activity by Activating NF-kappaB Pathway in Endotoxemic Mice, PLoS One, vol.10, 2015.

J. T. Benjamin, NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression, J Immunol, vol.185, pp.4896-4903, 2010.

Q. Qi, X. Wang, G. Strizich, and T. Wang, Genetic Determinants of Type 2 Diabetes in Asians, International journal of diabetology & vascular disease research, 2015.

Y. Han, Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia, 2017.

J. J. Gilchrist, Genetic variation in VAC14 is associated with bacteremia secondary to diverse pathogens in African children, Proceedings of the National Academy of Sciences, 2018.

L. Wang, Resistin polymorphisms are associated with rheumatoid arthritis susceptibility in Chinese Han subjects, 2018.

A. Yan, Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population, Aging and Disease, vol.7, pp.593-603, 2016.

M. Chang, Resistin reinforces interferon ?-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms, Scientific Reports, vol.6, 2016.

X. X. Yan, Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients, Atherosclerosis, vol.205, pp.544-548, 2009.

Y. Wang, The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes, J Diabetes Res, 2016.

S. Giovannini, Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects, Cardiovasc Diabetol, vol.16, 2017.

F. Zhang, sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells, Sci Rep, vol.7, 2017.

G. Basta, Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I, Coron Artery Dis, vol.22, pp.590-594, 2011.

M. Jabaudon, Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01919226

J. C. Jang, Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction, Proceedings of the National Academy of Sciences, 2017.